|
|
| Program-SHV |
|
| Track Infomation |
|
| Track 1 : Hepatisis C Virus |
|
Session Info |
Track 1-1: Hepatitis C: Basic Virology & Immunology
Time: 16:10-17:30, July 31, 2010 (Saturday) Place: Room No. 203, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Young S. Hahn, Professor, Berine Carter Center for Immunology Research, University of Virginia School of Medicine, USA |
16:10-16:30 |
Title: Controlling Immune Mediated Pathology in Acute Virus Infection
Dr. Thomas J. Braciale, Professor & Director, Carter Immunology Center, University of Virginia Health Systems, USA |
16:30-16:50 |
Title: HCV+Hepatocytes Induce Human Regulatory CD4+T Cells through the Production of TGF-b
Dr. Young S. Hahn, Professor, Berine Carter Center for Immunology Research, University of Virginia School of Medicine, USA |
16:50-17:10 |
Title: Phosphatidylinositol 4 Kinase Is a Host Factor Involved in Hepatitis C Virus Proliferation
Dr. Soon B. Hwang, Professor, National Research Laboratory of Hepatitis C Virus, Ilsong Institute of Life Science, Hallym University, Korea |
17:10-17:30 |
Title: Presence of Hepatitis C Virus DNA Sequences in the DNA of Infected Patients
Dr. Ami Klein, Professor, Department of Medical Laboratories, Meir Medical Center, Israel |
|
Track 1-2: Hepatitis C Clinical Course and Therapy
Time: 13:30-17:10, July 31, 2010 (Saturday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Joseph K. Lim, Director, Yale Viral Hepatitis Program, Yale University School of Medicine, USA |
13:30-13:50 |
Title: Insulin Resistance and Hepatitis C: Implications for Antiviral Therapy
Dr. Joseph K. Lim, Director, Yale Viral Hepatitis Program, Yale University School of Medicine, USA |
13:50-14:10 |
Title: Efficacy and Clinical Response to Reiferon Retard? in Patients with Chronic Hepatitis C in Egypt
Dr. Mohamed Abdel Hamid, Professor & Director, Viral Hepatitis Research Lab, National Hepatology and Tropical Institute, Egypt |
14:10-14:30 |
Title: Insulin Resistance and a Role of Novel Adipokines in Chronic Hepatitis C
Dr. Michael Kukla, Assistant, Department of Physiology in Zabrze, Medical University of Silesia in Katowice, Poland |
14:30-14:50 |
Title: Clinical Features of HCV
Dr. Suzan El Naghy, Assistant Professor, National Hepatology &Tropical Medicine Research Institute, Egypt |
14:50-15:10 |
Title: Treatment of Chronic Hepatitis C in Children and Adolescents
Dr. Stefan Wirth, Professor, HELIOS Children’s Hospital Wuppertal, Witten-Herdecke-University, Germany |
15:10-15:30 |
Coffee Break |
15:30-15:50 |
Title: Psychiatric Concerns in Patients with Chronic Hepatitis C
Dr. Rosa Quelhas Ferreira, Psychiatrist, Mental Health Department-Psychiatry Service, Pedro Hispano General Hospital, Matosinhos' Local Health Unit, Portugal |
15:50-16:10 |
Title: Correlation Between Interferon Alpha Receptor 2 Expression by Peripheral Blood Monocytes, Serum 2'-5'Oligoadenylate Synthtase, and Early Viral Response In Patients with a High Viral Load of Hepatitis C Virus Genotype 1 Showing Substitution Of Amino Acid 70 In the Core Region
Dr. Koji Ishii, Associate Professor, Toho University, Japan |
16:10-16:30 |
Title: Retinopathy Associated with Interferon-α and Ribavirin Combination Therapy in Patients with Chronic Hepatitis C: Case Report and Review of Literature
Dr. Konosuke Nakaji, Attendant, Department of Gastroenterology, Aishinkai Nakae Hospital, Japan |
16:30-16:50 |
Title: Acute /Recent HCV Infection, Clinical Course and Outcome, Host and Viral Characteristics
Dr. Tengiz Tsertsvadze, Director General, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi State University, Georgia |
16:50-17:10 |
Title: Sustained Virological Response in A Predominantly Hepatitis C Genotype 4
Dr. Yaser Dahlan, Consultant, National GUard Health Affairs, Saudi Arabia |
|
Track 1-3: HCV Virology
Time: 09:00-10:20, August 1, 2010 (Sunday) Place: Room No. 204, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Xiaoyu Li, Assistant Professor, Division of Gastroenterology and Hepatology, College of Medicine-Jacksonville, University of Florida, USA |
09:00-09:20 |
Title: Determination of Genotypes of Human Hepatitis C Virus Species According to Genomic Secondary Structure
Dr. Massimo Giangaspero, Professor, Veterinary Microbiology, School of Veterinary Medicine, Faculty of Agriculture, Iwate University, Japan |
09:20-09:40 |
Title: Autophagic Mechanism and Production of HCV Particles
Dr. Isei Tanida, Section Chief, Laboratory of Biomembranes, Department of Cell Biology and Biochemistry, National Institute of Infectious Diseases, Japan |
09:40-10:00 |
Title: Interferon Induced Anti-hepatitis C Virus Activities
Dr. Xiaoyu Li, Assistant Professor, Division of Gastroenterology and Hepatology, College of Medicine-Jacksonville, University of Florida, USA |
10:00-10:20 |
Title: Molecular Mechanisms of Hepatitis C Virus-associated Steatosis
Dr. Qiang Liu, Scientist, Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada |
10:20-10:40 |
Coffee Break |
|
Track 1-4: HCV Quasispecies & Kinetics
Time: 10:40-11:20, August 1, 2010 (Sunday) Place: Room No. 204, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Liam Fanning, Director, Molecular Virology, University College Cork, Ireland |
10:40-11:00 |
Title: Quasispecies: Future Proofing RNA Viruses
Dr. Liam Fanning, Director, Molecular Virology, University College Cork, Ireland |
11:00-11:20 |
Title: Quantification of Hepatitis C Virus Genotype 1b Codon 70 Wild and Mutant Types and Their Response to PEG-IFN/RBV Treatment
Dr. Naoya Kato, Assistant Professor & Director, Unit of Disease Control Genome Medicine, Institute of Medical Science, University of Tokyo, Japan |
|
Track 1-5: New Agents for Hepatitis C Clinical
Time: 15:30-17:10, August 1, 2010 (Sunday) Place: Room No. 202, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Xavier Morelli, Group Leader, IMR Laborator, Centre National de la Recherche Scientifique, France |
Session Co-chair: |
Dr. Robert Flisiak, Head, Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland |
15:30-15:50 |
Title: Investigational Drugs for Hepatitis C
Dr. Robert Flisiak, Head, Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland |
15:50-16:10 |
Title: Cyclophilins as a New Therapeutic Target in the Treatment of HCV
Dr. Rafael Crabbe, Medical Director, Debiopharm SA, Switzerland |
16:10-16:30 |
Title: Identification of Aallosteric Inhibitors Blocking the Hepatitis C Virus Polymerase NS5B in the RNA Synthesis Initiation Step
Dr. Xavier Morelli, Group Leader, IMR Laborator, Centre National de la Recherche Scientifique, France |
16:30-16:50 |
Title: Phosphoramidate Dinucleosides as Hepatitis C Virus Polymerase Inhibitors
Dr. Helene Dutartre, Senior Scientist, Charge de Recherche INSERM (CR1), USA |
16:50-17:10 |
Title: Historical Perspective of Host Factor Targeting Treatment in Viral Hepatitis
Dr. Kazuaki Inoue, Professor, Showa University Fujigaoka Hospital, Japan |
|
Track 1-6: HCV Epidemiology
Time: 09:00-11:00, August 2, 2010 (Monday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Emmanuel Drouet, Group Leader, Grenoble University, France |
09:00-09:20 |
Title: Detection of Hepatitis C Virus (HCV) RNA Sequences in Orally Infected Aedes caspius and Aedes vexans Mosquitoes (Diptera: Culicidae)
Dr. Emmanuel Drouet, Group Leader, Grenoble University, France |
09:20-09:40 |
Title: Hepatitis C: A Patient Journey from a Psychiatrist's Perspective
Dr. Vellingiri Raja Badrakalimuthu, Specialty Registrar, Old Age & Liaison Psychiatry, Addenbrooke's Hospital, UK |
09:40-10:00 |
Title: The Guidelines for the Prevention of In-hospital Infection of Viral Hepatitis C in Dialysis Patients
Dr. Takashi Akiba, Professor, Tokyo Women's Medical University, Japan |
10:00-10:20 |
Title: Hepatitis C Viral Infection: A Single Center Experience
Dr. Essam Elsawy, Director, Clinical Microbiology Laboratory, Urology & Nephrology Center, Mansoura University, Egypt |
10:20-10:40 |
Coffee Break |
10:40-11:00 |
Title: Prevention of HCV in Developing Countries: The Role of Nosocomial Transmission
Dr. Ahmed El Ray, Professor, Theodor Bilharz Research Institute, Ministry of Scientific Research, Egypt |
|
Track 1-7: Immunology of HCV Infection
Time: 13:30-15:30, August 2, 2010 (Monday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Francois Habersetzer, Strasbourg University Hospitals, Inserm 748, University of Strasbourg, France |
13:30-13:50 |
Title: Therapeutic Vaccination Based on a Recombinant MVA-HCV (TG4040) Virus Expressing Non Structural Proteins
Dr. Francois Habersetzer, Strasbourg University Hospitals, Inserm 748, University of Strasbourg, France |
13:50-14:10 |
Title: Strategy of Medical Treatment for Patients with HCV Infection Following Living Donor Liver Transplantation
Dr. Shinji Uemoto, Professor, Kyoto University Graduate School of Medicine, Japan |
14:10-14:30 |
Title: Effects of NKG2D and MICA Genetic Polymorphisms on Hepatitis C Virus Infection
Dr. Kengo Yoshida, Research Scientist, Immunology Laboratory, Department of
Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation, Japan |
14:30-15:10 |
Title: Altered Natural Killer Cell Function in Chronic HCV Infection
Dr. Gabriella Par, Assistant Professor, First Department of Medicine, University of Pecs, Hungary |
15:10-15:30 |
Title: Evaluation of Diagnostic Techniques of Hepatitis C Virus
Dr. Recep Kesli, Konya Education and Research Hospital, Molecular Diagnostic Unit, Turkey |
|
Track 1-8: HCV Cell Biology & Antiviral Effects
Time: 09:00-10:15, August 3, 2010 (Tuesday) Place: Room No. 204, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Marc Windisch, Head, Applied Molecular Virology Unit, Department of Biology Institut Pasteur Korea, South Korea |
09:00-09:25 |
Title: Characterization of Novel Anti-viral Compounds Identified by a Phenotypic Cell Based Screening Approach Using HCVcc
Dr. Marc P. Windisch, Head, Applied Molecular Virology Unit, Department of Biology Institute Pasteur Korea, South Korea |
09:25-09:50 |
Title: Unraveling the Fundamental Details of Hepatitis C Virus Entry into Hepatocytes by Optical and Electron Microscopy : Toward the Comprehension of the Mode of Action of Entry Inhibitors as Antivirals
Dr. Eve-Isabelle Pecheur, Institute of Biology and Chemistry of Proteins CNRS, France |
09:50-10:15 |
Title: HCV and Ethanol Dysregulate MHC Class I-dependent Antigen Presentation in Liver Cells
Dr. Natalia Osna, Assistant Professor, University of Nebraska Medical Center, VA Medical Center, USA |
10:15-10:30 |
Coffee Break |
|
Track 1-9: New Therapies for Hepatitis C: Preclinical
Time: 10:30-11:50, August 3, 2010 (Tuesday) Place: Room No. 204, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Seong-Wook Lee, Professor, Department of Molecular Biology, Dankook University, Korea |
10:30-10:50 |
Title: RNA Aptamer as an Agent against HCV Replication
Dr. Seong-Wook Lee, Professor, Department of Molecular Biology, Dankook University, Korea |
10:50-11:10 |
Title: Novel Nonimmunosupressive Cyclophillin A Inhibitor with Targets for Anti-HCVl Strategies
Dr. Sung Soo Kim, Director, MRC for ROS Research, Kyung Hee University School of Medicine, South Korea |
11:10-11:30 |
Title: Characterization of Thiobarbituric Acid Derivatives as Iinhibitors of HCV NS5B Polymerase
Dr. Heejoon Myung, Professor, Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Korea |
11:30-11:50 |
Title: Broadly Neutralizing Human Antibodies to Hepatitis C Virus E2 Glycoprotein Produced on PER. C6? Cells
Dr. Ingrid van den NieuwenhoFloor, Progect Leader, Innovation & Discovery Laboratory at Crucell, The Netherlands |
|
Track 1-10: Therapy of Hepatitis C: Current Issues
Time: 13:30-16:50, August 3, 2010 (Tuesday) Place: Room No. 202, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Sandeep Mukherjee, Associate Professor, The University of Nebraska Medical Center, USA |
Session Co-chair: |
Dr. Chia-Yen Dai, Professor &Director, Occupational and Environmental Medicine, Preventive Medicine, College of Medicine, Kaohsiung Medical University, Taiwan |
13:30-13:50 |
Title: Treatment of Hepatitits C after Liver Transplantation
Dr. Sandeep Mukherjee, Associate Professor, The University of Nebraska Medical Center, USA |
13:50-14:10 |
Title: Hepatitis C, Insulin Resistance, and the Metabolic Syndrome: Mechanism and Clinical Implications
Dr. Assy Nimer, Head, ZIV Medical Center, Israel |
14:10-14:30 |
Title: Silybin and HCV Chronic Infection: A New Possibility of Treatment
Dr. Carmela Loguercio, Professor, II University Federico II Naples. Italy |
14:30-14:50 |
Title: Contribution of Hepatic Steatosis and Aadipokines in Resistance Formation to the Current Anti-viral Therapy for Chronic Hepatitis C
Dr. Kenichi Ikejima, Associate Professor, Department of Gastroeterology, JuntendoUniversity School of Medicine, Japan |
14:50-15:10 |
Title: The Role of Surgery in the Treatment of Hepatitis C Infection
Dr. Georgios Tsoulfas, Assistant Professor, Department of Surgery, Aristoteleion University of Thessaloniki, Greece |
15:10-15:30 |
Coffee Break |
15:30-15:50 |
Title: Response to Treatment in Patients with HCV Genotype 4 with Normal and Abnormal Transaminases Effect of Schistosmoiasis Co-infection and Stage of Hepatic Fibrosis
Dr. Moutaz Derbala, Professor &Consultant, Hamad Medical Corporation, Qatar |
15:50-16:10 |
Title: The Need of Administering Growth Factors during the Present Antiviral Hepatitis C Therapy
Dr. Teresa Casanovas Taltavull, Hospital Universitari de Bellvitge, Spain |
16:10-16:30 |
Title: Outcomes of a Large, Nosocomial Outbreak of HCV in an Oncology Clinic
Dr. Mark E. Mailliard, Professor & ChieFloor, University of Nebraska College of Medicine, USA |
16:30-16:50 |
Title: Current Therapy of Chronic Hepatitis C: The Experiences in Taiwan
Dr. Chia-Yen Dai, Professor & Director, Occupational and Environmental Medicine, Preventive Medicine, College of Medicine, Kaohsiung Medical University, Taiwan |
|
|
| Track 2 : Hepatitis B and D Virus |
|
Session Info |
Track 2-1: HBV Therapy
Time: 13:30-16:10, August 1, 2010 (Sunday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Assy Nimer, Head, ZIV Medical Center, Israel |
13:30-13:50 |
Title: Pregnancy and Chronic Hepatitis B Infection
Dr. Sukran Kose, Head, Tepecik Research and Educational Hospital, Department of Infectious Diseases and Clinical Microbiology, Turkey |
13:50-14:10 |
Title: Management of Primary Antiviral Treatment Failure in CHB
Dr. Sang Hoon Ahn, Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yonsei University College of Medicine, Korea |
14:10-14:30 |
Title: Harnessing the RNA Interference Pathway to Counter HBV Infection
Dr. Patrick Arbuthnot, Director, Antiviral Gene Therapy Research Unit, University of the Witwatersrand, South Africa |
14:30-15:10 |
Title: Development of Lagociclovir Valactate to Management of Chronic Hepatitis B
Dr. Hong Zhang, Director, Medivir AB, Sweden |
15:10-15:30 |
Title: Issues in Hepatitis B Management in Post Liver Transplantation
Dr. Joye Varghese, Department of Medical Gastroenterology, Stanley Medical College. Hospital, Royapuram, Chennai, India |
15:30-15:50 |
Title: Role of Hepatitis B Virus as a Pathogen in Patients without HBsAg
Dr. Akihiro Tamori, Associate Professor, Department of Hepatology, Osaka City University Graduate School of Medicine, Japan |
15:50-16:10 |
Title: Antiviral Resistance & HBV
Dr. Calvin Pan, Associate Clinical Professor & Director, Mount Sinai School of Medicine, USA |
|
Track 2-2: HBV Epidemiology
Time: 16:10-17:10, August 1, 2010 (Sunday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Hua Shan, Associate Professor, Associate Medical Director, Johns Hopkins Medical Institutions, USA |
16:10-16:30 |
Title: Prevention of Transfusion Transmitted HBV Infection
Dr. Hua Shan, Associate Medical Director, Division of Transfusion Medicine, Department of Pathology, Johns Hopkins Medical Institutions, USA |
16:30-16:50 |
Title: Epidemiological Study of Hepatitis B Virus Infection in Northern Portugal
Dr. Ana Paula Guimaraes da Mota, Professor, Hospital Santo Antonio, Portugal |
16:50-17:10 |
?Title: Epidemiology and Treatment of HBV infection in the Greek Population
Dr. Polyxeni Agorastou, Department of Gastroenterology, Aristoteleion University of Thessaloniki, Greece |
|
Track 2-3: Issues in Control of HBV
Time: 11:00-12:00, August 2, 2010 (Monday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Emmanuel Drouet, Group Leader, Grenoble University, France |
11:00-11:20 |
Title: A Novel Approach for Prevention of HBV Mother-to-Child Transmission(MTCT)
Dr. Noriyuki Inaba, Vice President, Dokkyo Medical University, Japan |
11:20-11:40 |
Title: Challenges and Emerging Medico-social Issues in Prevention of Mother-to-Child Transmission of Hepatitis B Virus Programs in Low-resource Settings
Dr. Joseph Onakewhor, Professor, University of Benin City, Nigeria |
11:40-12:00 |
Title: Novel Properties of Hepatitis B Virus Reverse Transcriptase
Dr. Kyongmin Kim, Associate Professor, Ajou University, South Korea |
|
Track 2-4: HBV Immunology and Vaccine
Time: 15:30-17:10, August 2, 2010 (Monday) Place: Room No. 206, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Kyung Dong Bae, Head of Technical Service Team-Vaccine Research Institute, CrucellBerna Biotech Korea, South Korea |
15:30-15:55 |
Title: HBV Immunology and Vacccine
Dr. Hiroyasu Ito, Gifu University Graduate School of Medicine, Japan |
15:55-16:20 |
Title: HBV Immunology in High Prevalence Country
Dr. Prapan Jutavijittum, Chairman, Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand |
16:20-16:45 |
Title: Overview of Innovative Hepatitis B Vaccines
Dr. Kyung Dong Bae, Head of Technical Service Team-Vaccine Research Institute, CrucellBerna Biotech Korea, South Korea |
16:45-17:10 |
Title: Determination of Immune Memory to Hepatitis B Vaccination through Early Booster Response
in College Students Who Had Completed Neonatal Hepatitis B Vaccines
Dr. Chyi-Feng Jan, Clinical Assisted Professor, Department of Family Medicine, College of Family Medicine, National Taiwan University, Taiwan |
|
|
| Track 3 : Hepatitis A and E Virus |
|
Track Info |
Track 3-1: Hepatitis A and E Virus Epidemiology
Time: 14:45-17:10, , August 1, 2010 (Sunday) Place: Room No. 204, 2nd Floor, Convention Hall, BEXCO
|
Session Chair: |
Dr. Michael O. Favorov, Deputy Director-General, International Vaccine Institute, SNU Research Park, South Korea |
14:45-15:10 |
Title: Hepatitis E Emerging Disease: Epidemiology, Diagnostics and Vaccine Development
Dr. Michael O. Favorov, Deputy Director-General, International Vaccine Institute, SNU Research Park, Korea |
15:10-15:30 |
Coffee Break |
15:30-15:55 |
Title: Unveil HEV Infection in the Developed World
Dr. Wikrom Karnsakul, Assistant Professor, Johns Hopkins University School of Medicine, USA |
15:55-16:20 |
Title: Mussels Sea Farming in La Spezia Gulf (North-western Italy): Monitoring HAV Contamination of Local Production
Dr. Maria Goria, Director, Istituto Zooprofilattico Sperimentale del Piemonte, Italy |
16:20-16:45 |
Title: Hepatits A Virus and the Safety of Plasma Products
Dr. In Seop Kim, Associate Professor, Department of Biological Sciences, Hannam University, South Korea |
16:45-17:10 |
Title: Serological, Virological and Clinical Markers in HAV- (or HEV-) Infected Individuals
Dr. Abdelwahid Saeed Ali, Associate Professor, King Khalid University, Saudi Arabia |
|
|
| Track 4 : Virus and Liver Cancer |
|
Track Info |
Track 4-1: Hepatocellular Carcinoma (HCC)
Time: 09:00-12:20, August 3, 2010 (Tuesday) Place: Room No. 203, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Yick Pang Ching, Assistant Professor, Department of Anatomy, The University of Hong Kong, China |
Co-chair: |
Dr. Judy Yam, Assistant Professor, Department of Pathology, The University of Hong Kong, Hong Kong, China |
09:00-09:20 |
Title: Stromal Invasion of Hepatocellular Carcinoma (HCC): International Consensus of Histological Diagnosis of Well Differentiad HCC
Dr. Fukuo Kondo, Professor, Department of Pathology, Teikyo University Faculty of Medicine, Japan |
09:20-09:40 |
Title: The Role of HBx Oncoprotein in HCC Metastasis
Dr. Yick Pang Ching, Assistant Professor, Department of Anatomy, The University of Hong Kong, China |
09:40-10:00 |
Title: Genomics of Hepatocellular Carcinoma
Dr. Siu Tim Cheung, Assistant Professor, Department of Surgery, The University of Hong Kong, Hong Kong, China |
10:00-10:20 |
Title: Role of Focal Adhesion Proteins in Hepatocellular Carcinoma
Dr. Judy Yam, Assistant Professor, Department of Pathology, The University of Hong Kong, Hong Kong, China |
10:20-10:40 |
Title: Relation between HBV and HCC
Dr. Peter Michielsen, Vice Chairman, University Hospital Antwerp, Belgium |
10:40-11:00 |
Title: Epigenetic Alteration during HCV-related Hunan Hepatocarcinogenesis and Its Clinical Implication
Dr. Naoshi Nishida, Department of Gastroenterology and Hepatology, Kyoto University, Graduate School of Medicine, Japan |
11:00-11:20 |
Title: Hepatocellular Carcinoma, Now and Future
Dr. Kyuichi Tanikawa, Director, International Institute for Liver Research, Japan |
11:20-11:40 |
Title: C/EBPalpha is Up-Regulated in a Subset of Human Primary Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation
Dr. Guo-Dong Lu, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore |
11:40-12:00 |
Title: Prognostic Significance of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma
Dr. Mahmoud El-Bendary, Assisstant Professor, Mansoura University, Egypt |
12:00-12:20 |
Title: How to Model Hepatitis Induced Hepatocarcinogenesis
Dr. Johannes Haybaeck, Institute of Pathology, Medical University of Graz, Austria |
|
Track 4-2: Biomarkers for HCC
Time: 13:30-14:20, August 3, 2010 (Tuesday) Place: Room No. 203, 2nd Floor, Convention Hall, BEXCO |
Session Chair: |
Dr. Nancy K Man, Associate Professor, Department of Surgery and Centre for Cancer Research, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China |
13:30-13:55 |
Title: Non-invasive Biomarkers as Early Predictors for HCV-induced Hepatic Fibrosis and Carcingenesis
Dr. Eman EL-Ahwany, Associate Professor, Immunology Department, Theodor Bilharz Research Institute, Egypt |
13:55-14:20 |
Title: Prognostic Biomarkers of HCC: Systems Biology Approaches
Dr. Ju-Seog Lee, Assistant Professor, Department of Systems Biology, UT MD Anderson Cancer Center, USA |
|
Track 4-3: Therapy of HCC
Time: 14:20-16:45, August 3, 2010 (Tuesday) Place: Room No. 203, 2ndFloor, Convention Hall, BEXCO |
Session Chair: |
Dr. Nancy K Man, Associate Professor, Department of Surgery and Centre for Cancer Research, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China |
14:20-14:45 |
Title: Inflammation and Liver Cancer Progression-Molecular Mechanism and Novel Therapies
Dr. Nancy K Man, Associate Professor, Department of Surgery and Centre for Cancer Research, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China |
14:45-15:10 |
Title: Hepatocellular Carcinoma: Current Management and Future Trends
Dr. Dimitrios Dimitroulopoulos, Consultant, Gastroenterology Department, "Agios Savvas" Cancer Hospital, Greece |
15:10-15:30 |
Coffee Break |
15:30-15:55 |
Title: A Phase 1 Study of the Combination Chemotherapy of Sorafenib with Cisplatin Transcatheter Arterial Infusion for Advanced Hepatocellular Carcinoma
Dr. Atsushi Hagihara, Lecturer, Department of Hepatology, Osaka City University, Japan |
15:55-16:20 |
Title: Effective and Safe Treatment of Hepatocellular Carcinoma
Dr. Shozo Iwamoto, Iwamoto Hospital, Japan |
16:20-16:45 |
Title: Combined Intra-arterial Chemotherapy for Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
Dr. Hidenari Nagai, Assistant Professor, Division of Gastroenterology and Hepatology, Toho University Medical Center Omori Hospital, Japan |
|
|
| |
|
Organizers & SAB
